Dr. Peter Soukas, the director of peripheral vascular interventional laboratory at The Miriam Hospital, is highly enthusiastic about Cardiac Shockwave Therapy and its potential in treating arterial blockages. This innovative research has led to an FDA approved treatment for calcium blockages in coronary and leg arteries. According to Soukas, calcium blockages are a major obstacle in treating arterial blockages, and this therapy offers a minimally invasive solution that can lead to extended durability of the outcome.
One beneficiary of this treatment is Bruce Barton, who faced multiple blocked arteries and the possibility of losing a toe, foot or part of his leg. Barton underwent eight failed attempts at clearing the blockages before seeking help at The Miriam Hospital. There, he was introduced to Cardiac Shockwave Therapy, which utilizes high frequency ultrasonic waves to crack and fissure calcium deposits in the arteries.
The procedure involves preparing the vessels before following up with a drug coated balloon or stent for extended durability of the outcome. The Miriam Hospital has been involved in clinical trials for Cardiac Shockwave Therapy since 2017 and has seen positive results in over 500 cases. Since receiving the treatment, Barton has reported being able to walk three miles rather than just 100 yards.